Alberta Reappraising AIDS Society |
|
| |
David Crowe, President Phone: +1-403-289-6609 Fax: +1-403-289-6658 Email: David.Crowe@aras.ab.ca Kathleen Newell, Treasurer | Box 61037, Kensington Postal Outlet Calgary, Alberta T2N 4S6 Canada | |
IV Drug Abuse
IV drug abuse is certainly associated with AIDS, but it is also associated with a number of health conditions related to a combination of the direct effects of the drugs, substances used to 'cut' the drugs and the living conditions of drug users - poor nutrition and sanitation, often homeless and so forth. Drug addicts have always had serious health problems, often associated with immune suppression, such as Tuberculosis. Can HIV now be blamed for some or all of these problems?
The study was conducted with non-governmental organizations (NGOs) in three locations with high concentrations of IDU [intravenous drug users]: Kiev, Odessa and Makeevka/ Donetsk [in the Ukraine]
891 individuals were recruited
In order to provide a valid assessment of variables associated with HIV status, we omitted from further analyses the 113 participants who were aware that they were HIV positive prior to entering the study [leaving 778]
those who were HIV positive were significantly older and had been injecting longer than those who were HIV negative
Females were more likely to be HIV positive as were those who had been arrested. Having had syphilis, hepatitis B or hepatitis C was associated with HIV infection. Sedative/opiate mixture was the only drug type predictive of HIV. Daily injecting was associated with being HIV positive, as was front/back loading with a dealer. Using a previously used syringe was not associated with HIV infection. With regard to sexual risk behaviors, those who were abstinent were more likely to be HIV positive than those who were sexually active. Those who had an HIV-positive sex partner, however, were twice as likely to be HIV positive themselves as those who did not have an HIV-positive partner or who did not know the status of their partner
we were somewhat surprised to find that using a used needle was not related to HIV status.
Booth RE et al. Predictors of HIV sero-status among drug injectors at three Ukraine sites. AIDS. 2006 Nov 14;20(17):2217-23.
The strongest predictor of anaemia was frequency of injecting drugs. Less than half the study population (41%) injected more than 10 times per month, whereas 84% of the people in this group had anaemia
van der Werf MJ et al. Prevalence, incidence and risk factors of anaemia in HIV-positive and HIV-negative drug users. Addiction. 2000 Mar;95(3):383-92.
the mean duration of drug use preceding the first registered admission [to this Swiss hospital] was 6.7 years [unconfirmed HIV-negative], 7.1 years [confirmed negative] and 11.3 years [HIV-positive]
Scheidegger C, Zimmerli W. Incidence and spectrum of severe medical complications among hospitalised HIV-seronegative and HIV-seropositive narcotic drug users. AIDS. 1996 Oct;10(12):1407-14.
More than 15% of the HIV-1-seropositive [IV-drug-using] individuals had plasma vitamin A levels less than 1.05 micromol/L, a level consistent with vitamin A deficiency.
Semba RD et al. Increased Mortality Associated with Vitamin A Deficiency During HIV 1 Infection. Arch Intern Med. 1993 Sep 27;153:2149-54.
CD4 cell counts and percentages were obtained from 1,246 HIV-seronegative [IV drug using] subjects
9 had at least one CD4 cell count of <300 cells/microliter or a CD4[:CD8 ratio] <20%...4 subjects had CD4 counts <300 cells/microliter or CD4 < 20% for two points in time, meeting the current surveillance definition for ICL [HIV-free AIDS]...We also examined the data for the 21 subjects who had one CD4 count between 300 and 500 cells/microliter and for whom there was at least one follow-up data collection. None of these subjects progressed to a CD4 cell count of <300 cells/microliter or a CD4<20% at any follow-up visit. Five of these 21 subjects later seroconverted for HIV [indicating that low CD4 cell counts preceded infection, and could not have been caused by HIV]
Des Jarlais DC et al. CD4 lymphocytopenia among injecting drug users in New York City. J Acquir Immune Defic Syndr. 1993;6(7):820-2.
Human immunodeficiency virus (HIV) prevalence was studied in an unselected group of 216 female and transsexual prostitutes
All 128 females who did not admit to drug abuse were seronegative; 2 of the 52 females (3.8%) who admitted to intravenous drug abuse were seropositive.
Modan B et al. Prevalence of HIV antibodies in transsexual and female prostitutes. Am J Public Health. 1992 Apr;82(4):590-2.
Intravenous drug abusers appear to be at special risk of acquiring tuberculosis, and a high rate of infection in this group was reported well before AIDS began.
Goldman KP. AIDS and tuberculosis. BMJ. 1987;295:511-2.
The best single predictor of seropositivity at the start of the follow-up period was the frequency of drug injection 2 to 5 years prior
Des Jarlais DC et al. Development of AIDS, HIV seroconversion and potential cofactors for T4 cell loss in a cohort of intravenous drug users. AIDS. 1987;1:105-11.
© Copyright December 16, 2007: Alberta Reappraising AIDS Society